| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
RESEARCH AND PRACTICE |
The authors are with the Northern California Cancer Center, Union City. Scarlett S. Lin is also with the Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, Calif.
Correspondence: Requests for reprints should be sent to Scarlett S. Lin, MPH, Northern California Cancer Center, 32960 Alvarado-Niles Rd, Suite 600, Union City, CA 94587 (e-mail: slin{at}nccc.org).
 |
INTRODUCTION |
|---|
 TOP INTRODUCTION References |
|---|
The population-based Surveillance, Epidemiology, and End Results (SEER) program represents an important resource for the study of cancer incidence and outcomes in immigrant and minority racial/ethnic populations. Information on birthplace, an indicator of migrant status, is routinely collected by SEER registries and is generally derived from a patient’s medical records or death certificate.2 Unfortunately, these data are problematic for 2 reasons. First, to our knowledge, birthplace information in these registries is not validated, and thus its accuracy is unknown. Second, birthplace information is missing for a substantial proportion of patients, and its level of completeness continually decreases.3
Despite these methodological problems, this variable continues to be used in analyses of cancer incidence among Asian subgroups and their descendants,4–11 examinations of the relationship of birthplace to tumor size and stage among Asians12 and Hispanics,13 and investigations of the effect of birthplace on breast cancer survival among Asians.14 Hoping to inform and improve the quality of future analyses of birthplace as it relates to cancer patterns, we outline here some of our ongoing research on the utility of the birthplace variable in the San Francisco/Oakland and San Jose/Monterey SEER registries and discuss the results of previously published studies in the light of our findings involving this variable.
We found that 67% of patients diagnosed in the period 1988 to 1996 had complete birthplace information in the registries.2 This percentage varied by race/ethnicity, with Vietnamese and other Southeast Asians having the highest level of complete data (88.5%) and non-Hispanic Whites having the lowest (65.3%). The most significant factor associated with birthplace completeness was vital status; information from death certificates can supplement existing information by supplying missing birthplace data.
In addition, completeness of the birthplace variable in the registries examined was not random but varied according to characteristics such as patient age, year of diagnosis, and hospital teaching status, ownership status, and size. Preliminary results from an ongoing study comparing registry data and selfreported birthplace revealed that the sensitivity and positive predictive value of birthplace data among specific Asian subgroups were quite high, indicating generally good validity (Table 1
). Overall, however, Asians with no birthplace information were less likely to be foreign born than Asians with birthplace information (Table 2). This pattern was seen across all Asian subgroups except for Vietnamese, of whom the vast majority were foreign born.
|
|
Similarly, in 2 recently published studies examining birthplace in relation to breast cancer tumor size and stage among Asians12 and Hispanics,13 24.2% of Asians and 37.3% of Hispanics with unknown birthplace data were excluded. As a result, the findings of these studies are subject to selection bias in that completeness of birthplace information was likely to be associated with the outcomes under investigation, given that breast cancer patients at advanced stages and with larger tumor sizes generally have worse survival rates than patients at earlier stages and with smaller tumor sizes.
Inclusion of birthplace information in research designs can result in the identification of vulnerable subpopulations to be targeted for public health services, and such data can provide etiological insights as well. However, if this increasingly important information is to be useful, hospitals need to adopt policies aimed at improving its collection; the quality and completeness of birthplace data can be improved only at the level of the reporting facilities.
|
Acknowledgments |
|---|
Human Participant Protection
Ethical clearance for this research was obtained from the institutional review board of the Northern California Cancer Center.
|
Footnotes |
|---|
S. S. Lin conducted the analysis and took the lead in writing the brief. C. A. Clarke, C. D. O’Malley, and G. M. Le contributed to interpretation of the data and revision of the brief.
Accepted for publication December 23, 2001.
|
References |
|---|
|
TOPINTRODUCTIONReferences |
|---|
2. Lin SS, O’Malley CD, Lui SW. Factors associated with missing birthplace information in a population-based cancer registry. Ethn Dis. 2001;11:598–605.[Medline]
3. SEER*Stat Version 4.0 on CD-ROM. Bethesda, Md: National Cancer Institute; 2001.
4. Flood DM, Weiss NS, Cook LS, Emerson JC, Schwartz SM, Potter JD. Colorectal cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control. 2000;11:403–411.[Medline]
5. Herrinton LJ, Stanford JL, Schwartz SM, Weiss NS. Ovarian cancer incidence among Asian migrants to the United States and their descendants. J Natl Cancer Inst. 1994;86:1336–1339.
6. Stanford JL, Herrinton LJ, Schwartz SM, Weiss NS. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology. 1995;6:181–183.[Medline]
7. Rossing MA, Schwartz SM, Weiss NS. Thyroid cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control. 1995;6:439–444.[Medline]
8. Herrinton LJ, Goldoft M, Schwartz SM, Weiss NS. The incidence of non-Hodgkin’s lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants. Cancer Causes Control. 1996;7:224–230.[Medline]
9. Rosenblatt KA, Weiss NS, Schwartz SM. Liver cancer in Asian migrants to the United States and their descendants. Cancer Causes Control. 1996;7:345–350.[Medline]
10. Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of adenocarcinoma of the prostate in Asian migrants to the United States and their descendants. J Urol. 1998;161:152–155.
11. Kamineni A, Williams MA, Schwartz SM, Cook LS, Weiss NS. The incidence of gastric carcinoma in Asian migrants to the United States and their descendants. Cancer Causes Control. 1999;10:77–83.[Medline]
12. Hedeen AN, White E, Taylor V. Ethnicity and birthplace in relation to tumor size and stage in Asian American women with breast cancer. Am J Public Health. 1999;89:1248–1252.
13. Hedeen AN, White E. Breast cancer size and stage in Hispanic American women, by birthplace, 1992–1995. Am J Public Health. 2001;91:122–125.[Abstract]
14. Pineda MD, White E, Kristal AR, Taylor V. Asian breast cancer survival in the US: a comparison between Asian immigrants, US-born Asian Americans and Caucasians. Int J Epidemiol. 2001;30:976–982.
15. Emerson SS, Emerson JC. Direct standardization of incidence rates in the presence of incomplete data. Stat Med. 1993;12:3–12.[Medline]
This article has been cited by other articles:
|
|
 |
|
  S. L. Gomez, G. M. Le, D. W. West, W. A. Satariano, and L. O'Connor Hospital Policy and Practice Regarding the Collection of Data on Race, Ethnicity, and Birthplace Am J Public Health, October 1, 2003; 93(10): 1685 - 1688. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
